Publicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (19)

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  3. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

2019

  1. Genome-wide association study of white blood cell counts in patients with ischemic stroke

    Stroke, Vol. 50, Núm. 12, pp. 3618-3621

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

  2. Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: A systematic review and meta-analysis

    Journal of Neuroimmunology, Vol. 274, Núm. 1-2, pp. 215-224

2013

  1. Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES

    Neurologia, Vol. 28, Núm. 6, pp. 332-339

2012

  1. Citicoline in the treatment of acute ischaemic stroke: An international, randomised, multicentre, placebo-controlled study (ICTUS trial)

    The Lancet, Vol. 380, Núm. 9839, pp. 349-357

2011

  1. Plan de asistencia sanitaria al ICTUS II. 2010

    Neurologia, Vol. 26, Núm. 7, pp. 383-396

2010

  1. Stroke with polyvascular atherothrombotic disease

    Atherosclerosis, Vol. 208, Núm. 2, pp. 587-592

2009

  1. Inflammation markers and prediction of post-stroke vascular disease recurrence: The MITICO study

    Journal of Neurology, Vol. 256, Núm. 2, pp. 217-224

2006

  1. Plan de atención sanitaria al ictus

    Neurologia, Vol. 21, Núm. 10, pp. 717-726

2005

  1. Headache in cerebral hemorrhage is associated with inflammatory markers and higher residual cavity

    Headache, Vol. 45, Núm. 9, pp. 1236-1243

  2. Molecular Signatures of Course and Prognosis of Intracerebral Hemorrhage

    Seminars in Cerebrovascular Diseases and Stroke, Vol. 5, Núm. 3, pp. 178-188

2003

  1. Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage

    Journal of Neurosurgery, Vol. 99, Núm. 1, pp. 65-70

  2. Revisión de consenso. Neuroprotección farmacológica en la isquemia cerebral: ¿Es todavía una opción terapéutica?

    Neurologia, Vol. 18, Núm. 7, pp. 368-384

  3. Tratamiento intravenoso con activador del plasminógeno tisular en la isquemia cerebral aguda

    Medicina Clinica, Vol. 120, Núm. 1, pp. 1-5

2002

  1. Molecular signatures of brain injury after intracerebral hemorrhage

    Neurology, Vol. 58, Núm. 4, pp. 624-629